Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Appro...

par Hnik, Peter, Wasan, Ellen K., Wasan, Kishor M.
Publié dans Antimicrob Agents Chemother (2020)

Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle...

par Wasan, Kishor M., Wasan, Ellen K., Hnik, Peter
Publié dans Antimicrob Agents Chemother (2020)

The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?

par Cuddihy, Grace, Wasan, Ellen K., Di, Yunyun, Wasan, Kishor M.
Publié dans Pharmaceutics (2019)

Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis

par Ibrahim, Fady, Sivak, Olena, Wasan, Ellen K, Bartlett, Karen, Wasan, Kishor M
Publié dans Lipids Health Dis (2013)

An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery

par Mohammed, Munawar A., Syeda, Jaweria T. M., Wasan, Kishor M., Wasan, Ellen K.
Publié dans Pharmaceutics (2017)

Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model

par Owen David, Zhao Jinying, Wasan Ellen K, Lin Molly, Gershkovich Pavel, Sivak Olena, Clement John G, Wasan Kishor M
Publié 2011-08-01

Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model

par Sivak, Olena, Gershkovich, Pavel, Lin, Molly, Wasan, Ellen K, Zhao, Jinying, Owen, David, Clement, John G, Wasan, Kishor M
Publié 2011

In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines

par Leon, Carlos G, Lee, Jinkyung, Bartlett, Karen, Gershkovich, Pavel, Wasan, Ellen K, Zhao, Jinying, Clement, John G, Wasan, Kishor M
Publié 2011

A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model

par Wasan, Ellen K., Gershkovich, Pavel, Zhao, Jinying, Zhu, Xiaohua, Werbovetz, Karl, Tidwell, Richard R., Clement, John G., Thornton, Sheila J., Wasan, Kishor M.
Publié 2010

Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains

par Wasan, Ellen K., Zhao, Jinying, Poteet, Joshua, Mohammed, Munawar A., Syeda, Jaweria, Orlowski, Tatiana, Soulsbury, Kevin, Cawthray, Jacqueline, Bunyamin, Amanda, Zhang, Chi, Fahlman, Brian M., Krol, Ed S.
Publié dans Pharmaceutics (2019)

Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis

par Di, Yunyun, Wasan, Ellen K., Cawthray, Jacqueline, Syeda, Jaweria, Ali, Munawar, Cooper, David M.L., Al-Dissi, Ahmad, Ashjaee, Nima, Cheng, Wubin, Johnston, James, Weekes, David M., Kostelnik, Thomas I., Orvig, Chris, Wasan, Kishor M.
Publié dans Bone Rep (2021)